How Mass Tort Settlement Grids Work
Unlike individual personal injury cases where each plaintiff negotiates individually with an insurance company, mass tort settlements typically use a points-based grid system that assigns each plaintiff's claim to an injury tier and calculates a settlement amount based on that tier. The grid is negotiated between the MDL Plaintiff Steering Committee and the defendant and announced when a global settlement is reached. Each plaintiff's claim is then reviewed by a settlement administrator who assigns it to the appropriate tier based on submitted medical records.
Factors That Increase Your Settlement Tier
The factors most likely to place your claim in a higher settlement tier include: (1) Complete mesh explantation, particularly if the explantation was a complex open procedure. (2) Multiple revision surgeries — each additional surgery reflects greater complication severity. (3) Documented bowel complication — adhesion-related bowel obstruction, fistula, or bowel resection are the highest-tier injuries. (4) Sepsis or other life-threatening complications requiring ICU care. (5) Permanent disability or documented inability to return to work. (6) Documented product identification — confirmed Davol/Bard or Ethicon product with lot number. (7) Complete, organized, and well-presented medical records submitted with the Plaintiff Fact Sheet.
Medicare and Medicaid Liens in Settlement
If Medicare or Medicaid paid for any of your mesh-related medical treatment, those programs have a legal right to be reimbursed from your settlement — a process called lien resolution. Medicare liens must be resolved as a condition of settlement under the Medicare Secondary Payer Act. Plaintiffs' attorneys typically work with lien resolution specialists to negotiate Medicare and Medicaid claims down to reduce the amount recovered from your settlement. This is a standard step in all mass tort resolutions and your attorney will handle it on your behalf.
Contingency Fees in Hernia Mesh Cases
Hernia mesh attorneys work exclusively on contingency — meaning no upfront cost to you and no fee unless your case resolves successfully. Standard contingency fees in mass tort cases range from 33 to 40 percent, with case expenses (medical record retrieval, expert witness costs, filing fees) typically advanced by the firm and deducted from the gross settlement before the attorney percentage is calculated. Common benefit fees — a portion of each settlement that funds the MDL's shared costs including Plaintiff Steering Committee work and expert witness development — are also deducted from the gross settlement amount.
Frequently Asked Questions
Related Pages
Davol and C.R. Bard Hernia Mesh Products
Davol Inc. and its parent C.R. Bard (now Becton Dickinson) manufactured the largest portfolio of recalled and litigation-linked hernia mesh products in the United States. Products including 3DMax, Ventralex ST, and the recalled Composix Kugel are at the center of MDL 2846 — one of the largest active medical device MDLs in federal court.
Hernia Mesh Infection Claims
Hernia mesh infection is a devastating complication because bacteria colonize the mesh material in treatment-resistant biofilms, usually requiring complete surgical removal. Mesh design characteristics — including pore size, material composition, and surface coatings — directly affect infection susceptibility, creating strong product liability theories.
Hernia Mesh Evidence — Building Your Claim
A strong hernia mesh claim rests on three evidentiary pillars: confirmed product identification (which specific mesh was implanted), documented complications in medical records, and expert opinions causally linking the mesh to the injuries. Gathering and preserving this evidence from the moment complications are identified is the single most important step a potential claimant can take.
Ethicon and Johnson and Johnson Hernia Mesh
Ethicon, a Johnson and Johnson subsidiary, manufactured the Physiomesh Flexible Composite — voluntarily withdrawn from global markets in May 2016 after independent registry data revealed reoperation rates two to three times higher than comparator meshes. Ethicon Physiomesh and related product claims are consolidated in MDL 2753 in the District of New Jersey and MCL 616 in New Jersey Superior Court.
Hernia Mesh Complications — What Can Go Wrong
Defective hernia mesh can cause a spectrum of complications from painful but treatable infections to catastrophic bowel perforation and sepsis. Understanding which complications are associated with mesh defects — versus routine surgical risks — is essential for evaluating whether a legal claim exists.
Hernia Mesh Revision Surgery — What It Involves
Hernia mesh revision surgery — including adhesiolysis, partial mesh removal, and complete explantation — is a significantly more complex and dangerous operation than the original hernia repair. The risks, costs, and recovery demands of revision surgery are core elements of damages in hernia mesh litigation.
Hernia Mesh Recall History — What the FDA Found
The FDA has issued safety communications, ordered 522 post-market surveillance studies, and presided over multiple hernia mesh recalls. The regulatory history establishes that manufacturers had notice of mesh complications well before many patients were implanted — a critical element of failure-to-warn and design defect claims.
Inguinal Hernia Mesh Claims
Inguinal hernia mesh repairs are the most common hernia surgery in the United States, accounting for approximately 800,000 procedures annually. The inguinal region's proximity to critical nerves and spermatic cord structures makes mesh complications in this location particularly likely to cause chronic, debilitating pain.
Ventral Hernia Mesh Claims
Ventral hernias — including incisional hernias following prior abdominal surgeries — are typically repaired with large sheets of synthetic mesh placed intra-abdominally or in the retromuscular space. The large surface area of ventral mesh in contact with bowel creates significant risk of adhesion, migration, and bowel obstruction.
Hernia Mesh MDL 2846 — What You Need to Know
MDL 2846 in the Southern District of Ohio is the federal coordination for all Davol/C.R. Bard hernia mesh cases. With over 20,000 cases and ongoing bellwether trials, understanding how the MDL works is essential for any potential claimant navigating this litigation.
Hernia Mesh Chronic Pain — Inguinodynia Claims
Chronic groin pain (inguinodynia) following hernia mesh repair affects an estimated 10 to 30 percent of patients in some surgical registry studies and is the most common basis for hernia mesh legal claims. Nerve entrapment by mesh fixation devices and mesh contracture are the primary mechanisms. Chronic pain claims are legally cognizable even without revision surgery.
Hernia Mesh (Davol/C.R. Bard) Lawsuit
Hernia mesh litigation is one of the largest ongoing mass tort actions in the United States. Polypropylene mesh devices implanted during inguinal, ventral, and incisional hernia repairs have been associated with a pattern of serious defects — including mesh shrinkage, migration, erosion into adjacent organs, bacterial colonization, and nerve entrapment — that manufacturers knew about for years before disclosing to physicians or patients. The primary defendants include Davol Inc. and its parent C.R. Bard (now part of Becton Dickinson), Ethicon (a Johnson and Johnson subsidiary), Atrium Medical, and Covidien (now part of Medtronic). The federal multidistrict litigation MDL 2846 in the Southern District of Ohio has consolidated thousands of Davol/C.R. Bard claims for coordinated pre-trial proceedings. Separately, Ethicon mesh cases are coordinated in New Jersey Superior Court (MCL 616). Patients who underwent hernia repair surgery and subsequently experienced complications are urged to seek legal evaluation immediately — statutes of limitations are running and evidence must be preserved.
View full case overview